NEWME and NEwMe diabetes
A Digital Therapeutics (DTx) Platform
The prevention & management of chronic diseases has been the focus of Eco-Fusion’s Digital Therapeutics for a good reason. The gold standard treatment of such conditions is largely based on guiding the patient through the process of acquiring healthier habits related to nutrition, exercise & medication adherence. Eco Fusion is adding a set of patented technologies for dealing with stress, sleep and general wellbeing. Our solution was shown to be clinically effective in reducing blood sugar of Type II patient by 18% within 8 weeks (a published article on the Journal of Medical Internet Research, 2017).
NewMe™ is an app & a web platform that connects patients and caregivers. It allows a medical professional or a team to deliver treatment, monitor its efficacy, and adjust it on a daily basis. The system provides a comprehensive overview of the patient’s health and progress. Treatment adjustments can be done with a few mouse clicks and delivered to the patient instantly.
These capabilities help improve diagnosis and treatment and enable scalability & long-term success. The platform has multiple programs such as NewMe Diabetes and could be customized to a variety of other indications. For example, our solution was clinically validated and shown to reduce a1c and weight within 8 weeks (with sustainability after 16 weeks and 6 months).
Real-time data acquisition
Data-source: Smartphone sensors, apps, wearables, wireless medical devices such as Digital Scales, Glucose and Blood Pressure monitors and Electronic Medical Records.
Push treatment to patient
Care team – patient communication
NewMe and NewMe Diabetes are oferred only through health organizations
If your organization is interested in offering NewMe to its patients, we invite you to contact us.